Lipid-lowering and anti-inflammatory effects of omega 3 ethyl esters and krill oil: A randomized, cross-over, clinical trial

Archives of Medical Science

Volumn 12, Issue 3, 2016, Pages 507-512

  Cicero, Arrigo F G ^a   Rosticci, Martina ^a   Morbini, Martino ^a   Cagnati, Marcella ^a   Grandi, Elisa ^a   Parini, Angelo ^a   Borghi, Claudio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Docosahexaenoic acid; Eicosapentaenoic acid; Hyperlipidemia; Inflammation; Krill oil; Omega 3 fatty acids

Indexed keywords

APOLIPOPROTEIN A1; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KRILL OIL; OMEGA 3 ACID ETHYL ESTER; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EVENING DOSAGE; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; RANDOMIZED CONTROLLED TRIAL;

EID: 84973449180     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2016.59923     Document Type: Article

References (24)

1. Cicero AF, De Sando V, Parini A, Borghi C. Polyunsaturated fatty acids application in internal medicine: beyond the established cardiovascular effects. Arch Med Sci 2012;8:784-93.
2. Cicero AF, Ertek S, Borghi C. Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. Curr Vasc Pharmacol 2009;7:330-7.
3. Cicero AF, Morbini M, Borghi C. Do we need "new" omega 3 polyunsaturated fatty acids formulations? Exp Opin Pharmacother 2014;4:1-4.
4. Ramprasath VR, Eyal I, Zchut S, Jones PJH. Enhanced increase of omega 3 index in healthy individuals with response to 4 week n-3 fatty acid supplementation from krill oil versus fish oil. Lipids Health Dis 2013;12:178.
5. Naguib YM. Antioxidant activities of astaxanthin and related carotenoids. J Agric Food Chem 2000;48:1150-4.
6. Ulven SM, Kirkhus B, Lamglait A, et al. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids 2011;46:37-46.
7. Cicero AF, Derosa G, Parini A, et al. Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects. Nutr Res 2013;33:622-8.
8. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999;45:2136-41.
9. Derosa G, Limas CP, Macías PC, Estrella A, Maffioli P. Dietary and nutraceutical approach to type 2 diabetes. Arch Med Sci 2014;10:336-44.
10. Mariscalco G, Sarzi Braga S, Banach M, et al. Preoperative n-3 polyunsatured fatty acids are associated with a decrease in the incidence of early atrial fibrillation following cardiac surgery. Angiology 2010;61:643-50.
11. Banach M, Serban C, Aronow WS, et al. Lipid, blood pressure and kidney update 2013. Int Urol Nephrol 2014;46:947-61.
12. Superko HR, Superko AR, Lundberg GP, et al. Omega-3 fatty acid blood levels clinical significance update. Curr Cardiovasc Risk Rep 2014;8:407.
13. Ghasemifard S, Turchini GM, Sinclair AJ. Omega-3 long chain fatty acid "bioavailability": a review of evidence and methodological considerations. Prog Lipid Res 2014;56C: 92-108.
14. Bunea R, El Farrah K, Deutsch L. Evaluation of the effects of neptune krill oil on the clinical course of hyperlipidemia. Alt Med Rev 2004;9:420-8.
15. Calder PC. Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta 2015;1851:469-84.
16. Deutsch L. Evaluation of the effect of Neptune Krill Oil on chronic inflammation and arthritic symptoms. J Am Coll Nutr 2007;26:39-48.
17. Banni S, Carta G, Murru E, et al. Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects. Nutr Metab 2011;8:7.
18. Konagai C, Yanagimoto K, Hayamizu K, Han L, Tsuji T, Koga Y. Effects of krill oil containing n-3 polyunsaturated fatty acids in phospholipid form on human brain function: a randomized controlled trial in healthy elderly volunteers. Clin Interv Aging 2013;8:1247-57.
19. Ferramosca A, Zara V. Modulation of hepatic steatosis by dietary fatty acids. World J Gastroenterol 2014;20:1746-55.
20. Cicero AF, Colletti A. Krill oil: evidence of a new source of polyunsaturated fatty acids with high bioavailability. Clin Lipidol 2015;10:1-4.
21. Sikora J, Kostka B, Marczyk I, Krajewska U, Chałubiñski M, Broncel M. Effect of statins on platelet function in patients with hyperlipidemia. Arch Med Sci 2013;9:622-8.
22. Guardado-Mendoza R, Prioletta A, Jiménez-Ceja LM, Sosale A, Folli F. The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus. Arch Med Sci 2013;9:936-43.
23. Aronow WS. Lipid-lowering therapy in older persons. Arch Med Sci 2015;11:43-56.
24. Banach M, Rizzo M, Toth PP, et al. Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci 2015;11:1-23.